MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.64 +0.54 (+1.97%)
Streaming Delayed Price Updated: 3:51 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,793,446
Open 27.16
Bid (Size) 27.63 (4,500)
Ask (Size) 27.64 (12,700)
Prev. Close 27.10
Today's Range 27.09 - 27.67
52wk Range 20.91 - 27.94
Shares Outstanding 5,606,688,356
Dividend Yield 6.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Implementation Pivot: How Accenture Defied the ‘SaaS-pocalypse’ with a Massive AI Rebound
As of February 27, 2026, the global technology sector is grappling with a profound identity crisis often dubbed the "SaaS-pocalypse." While many software-as-a-service providers have seen their... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Industrial Renaissance: Sector Surges 27% in Q4 2025 as Healthcare and Consumer Discretionary Lag
The fourth-quarter 2025 earnings season has delivered a definitive verdict on the health of the American economy: the "Industrial Renaissance" is no longer a forecast, but a realized phenomenon. While... 
Via MarketMinute
Topics Artificial Intelligence Economy

Performance

YTD
+9.7%
+9.7%
1 Month
+4.3%
+4.3%
3 Month
+7.4%
+7.4%
6 Month
+12.3%
+12.3%
1 Year
+4.6%
+4.6%

More News

Read More
News headline image
The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan
Via MarketMinute
Topics Artificial Intelligence ETFs
News headline image
Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?
Via Barchart.com
Topics Stocks
News headline image
The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines
Via Finterra
Topics Economy
News headline image
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Amneal (AMRX) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? ↗
Via Stocktwits
Topics Earnings
News headline image
2 Reasons to Like ZTS (and 1 Not So Much)
Via StockStory
Topics Stocks
News headline image
OPKO Health (OPK) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Love Dividends? 1 Stock to Buy Now With a Yield Over 6%.
Via Barchart.com
Topics Artificial Intelligence
News headline image
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
Via MarketMinute
Topics Economy Intellectual Property
News headline image
The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy
Via Finterra
Topics Economy
News headline image
This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday ↗
Via Benzinga
News headline image
Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q4 CY2025
Via StockStory
News headline image
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash ↗
Via Stocktwits
News headline image
Gilead’s Twice-Yearly HIV Breakthrough: A Paradigm Shift in Global Prevention and Market Dominance
Via MarketMinute
Topics Intellectual Property
News headline image
Eli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know. ↗
Via The Motley Fool
News headline image
Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment ↗
Via Benzinga
News headline image
Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment ↗
Via Benzinga
News headline image
Pfizer Stock: Is PFE Underperforming the Healthcare Sector?
Via Barchart.com
Topics ETFs Intellectual Property World Trade
News headline image
U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts ↗
Via Stocktwits
Topics Artificial Intelligence Earnings
News headline image
This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income ↗
Via The Motley Fool
Topics Intellectual Property
TinyGemsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Dr. Freda Lewis-Hall to Board and Scientific Advisory Committee Chair
Via Investor Brand Network

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 27.64
When was Pfizer last traded?
The last trade of Pfizer was at 02/27/26 03:51 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 154.94B
How many shares of Pfizer are outstanding?
Pfizer has 155B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story